1. Academic Validation
  2. Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time

Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time

  • Br J Haematol. 2006 Dec;135(5):683-7. doi: 10.1111/j.1365-2141.2006.06348.x.
Terra L Lasho 1 Animesh Pardanani Rebecca F McClure Ruben A Mesa Ross L Levine D Gary Gilliland Ayalew Tefferi
Affiliations

Affiliation

  • 1 Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Abstract

MPLW515L/K and JAK2V617F can co-exist in myelofibrosis with myeloid metaplasia (MMM). The chronology of clonal emergence was studied in three such cases using serially stored bone marrow. At diagnosis, a major MPL515 mutant clone was accompanied by a minor JAK2V617F clone in all three instances. At 25 time points over a period of 4-8 years, allele burden fluctuated but remained high for MPLW515L/K and low for JAK2V617F. We conclude that MPLW515L/K and JAK2V617F are both early events in MMM and allele burden, rather than the mere presence of these mutations, might be relevant to phenotypic variation in myeloproliferative disorders.

Figures